AAV Infection: Protection from Cancer-Reference-Cited by-同舟云学术

AAV Infection: Protection from Cancer

Published:2017-04 Issue:4 Volume:28 Page:323-327
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Srivastava Arun¹,Carter Barrie J.²

Affiliation:

1. Division of Cellular and Molecular Therapy, Departments of Pediatrics and Molecular Genetics and Microbiology, Powell Gene Therapy Center; Genetics Institute; University of Florida College of Medicine, Gainesville, Florida.

2. BioMarin Pharmaceutical, Inc., Novato, California.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2016.147

Reference70 articles.

1. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas

2. Adeno-Associated Virus Type 2 and Hepatocellular Carcinoma?

3. Adeno-associated Vector Toxicity—To Be or Not to Be?

4. Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution

5. Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell therapeutics and gene therapy for neurologic disorders;Neurotherapeutics;2024-07

2. Intrathecal AAV9/AP4M1 gene therapy for hereditary spastic paraplegia 50 shows safety and efficacy in preclinical studies;Journal of Clinical Investigation;2023-05-15

3. Adeno-Associated Virus 2 and Human Adenovirus F41 in Wastewater during Outbreak of Severe Acute Hepatitis in Children, Ireland;Emerging Infectious Diseases;2023-04

4. Gene therapy for liver diseases — progress and challenges;Nature Reviews Gastroenterology & Hepatology;2023-01-16

5. Evaluating the state of the science for adeno-associated virus integration: An integrated perspective;Molecular Therapy;2022-08